28 Apr 2025 Research & Development Spotlight Series, Episode 9 Investors | R&D Spotlights Series | Therapeutics
28 Apr 2025 Avacta Therapeutics Presents Preclinical and Translational Data from pre|CISION® Platform Candidates at 2025 AACR Annual Meeting Investors | Therapeutics
28 Apr 2025 Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting Investors | Therapeutics
31 Mar 2025 Avacta Provides Business Update for the First Quarter of 2025 Outlining Progress Against Strategic Objectives Investors
26 Mar 2025 Avacta Therapeutics Announces Presentations at 2025 AACR Annual Meeting Investors | Therapeutics
10 Mar 2025 Avacta Therapeutics to Present at the 2025 Leerink Global Healthcare Conference Investors
07 Mar 2025 Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion Cohorts Investors | Therapeutics